Summary of Significant Accounting Policies (Tables)

3 Months Ended

Dec. 31, 2023

Accounting Policies [Abstract]

Schedule of Restrictions on Cash and Cash Equivalents

The following table provides a reconciliation of the total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheets to the corresponding amounts reported on the Condensed Consolidated Statements of Cash Flows.

	December 31, 2023		December 31, 2022
Cash and cash equivalents	$	204	$	317
Restricted cash	98		227
Cash, cash equivalents and restricted cash	$	302	$	544

Schedule of Cash and Cash Equivalents

The following table provides a reconciliation of the total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheets to the corresponding amounts reported on the Condensed Consolidated Statements of Cash Flows.

	December 31, 2023		December 31, 2022
Cash and cash equivalents	$	204	$	317
Restricted cash	98		227
Cash, cash equivalents and restricted cash	$	302	$	544

Schedule of Shares Used in Computing Basic and Diluted Earnings Per Share

Shares used in computing basic and diluted earnings per share are as follows: 

	Three Months Ended December 31,
	2023	2022
Denominator (thousands of shares):
Weighted-average common shares outstanding — basic	209,782	209,934
Incremental shares issuable for stock options, common stock awards and Equity Units (a)	5,788	—
Weighted-average common shares outstanding — diluted	215,570	209,934

(a)For the three months ended December 31, 2022, 6,431 of incremental shares have been excluded as such shares would be antidilutive due to the net loss for the period. At December 31, 2023 and 2022, there were 8,285 and 6,625 shares, respectively, associated with outstanding stock option awards that were not included in the computation of diluted earnings per share above because their effect was antidilutive.